SFRP4 Is a Potential Biomarker for the Prognosis and Immunotherapy for Gastric Cancer

Figure 4

Association between SFRP4 expression and immune components, including lymphocytes and immunomodulators in patients with stomach adenocarcinoma. (a) Correlation between SFRP4 expression levels and lymphocytes. (b) Relationship between SFRP4 expression levels and immunoinhibitors. (c) Correlation between SFRP4 expression levels and immunostimulators.

(a)

(b)

(c)